Nxstage Medical (NXTM) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Equities rebound to close higher as surging Treasury yields recede
- Fed’s Jefferson sees no urgency for another rate increase
- Oil jumps 4% on reports China halts fuel exports, US troops head to Middle East
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equities rebound to close higher as surging Treasury yields recede
NxStage Reports Record Third Quarter Financial Results And Increases Financial Guidance For 2015
November 3, 2015 7:28 AM ESTLAWRENCE, Mass., Nov. 3, 2015 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported third quarter financial results above the top end of its guidance ranges.
Revenue for the third quarter of 2015 increased 15 percent to $86.5 million, compared with revenue of $75.3 million for the third quarter of 2014. The Company's revenue guidance range for the third quarter was $82.0 million to $83.0 million. The increase was driven by the System One segment which consists of Home and Critical... More
